Grb-2–associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A–endothelial NOS pathway
- aLaboratory of Vascular Biology, Institute of Molecular Medicine; and
- bDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Tasly Microcirculation Research Center, Peking University, Beijing 100871, China;
- cGenetic Laboratory of Development and Disease, Institute of Biotechnology, Beijing 100071, China;
- dNon-Human Primate Center, Institute of Molecular Medicine; and
- eAnimal Center, Peking University, Beijing 100871, China;
- fDepartment of Molecular Pathology, Institute of Pathology, University of Würzburg, D-97080 Würzburg, Germany;
- gLaboratory of Vascular and Cancer Biology, Model Animal Research Institute, Nanjing University, Nanjing 210061, China;
- hDepartment of Molecular Oncology, Tokyo Medical and Dental University, Tokyo 113-8510, Japan; and
- iDepartment of Pathology, School of Medicine, University of California at San Diego, La Jolla, CA 92093
See allHide authors and affiliations

Abstract
The intracellular signaling mechanisms underlying postnatal angiogenesis are incompletely understood. Herein we show that Grb-2–associated binder 1 (Gab1) plays a critical role in ischemic and VEGF-induced angiogenesis. Endothelium-specific Gab1 KO (EGKO) mice displayed impaired angiogenesis in the ischemic hindlimb despite normal induction of VEGF expression. Matrigel plugs with VEGF implanted in EGKO mice induced fewer capillaries than those in control mice. The vessels and endothelial cells (ECs) derived from EGKO mice were defective in vascular sprouting and tube formation induced by VEGF. Biochemical analyses revealed a substantial reduction of endothelial NOS (eNOS) activation in Gab1-deficient vessels and ECs following VEGF stimulation. Interestingly, the phosphorylation of Akt, an enzyme known to promote VEGF-induced eNOS activation, was increased in Gab1-deficient vessels and ECs whereas protein kinase A (PKA) activity was significantly decreased. Introduction of an active form of PKA rescued VEGF-induced eNOS activation and tube formation in EGKO ECs. Reexpression of WT or mutant Gab1 molecules in EGKO ECs revealed requirement of Gab1/Shp2 association for the activation of PKA and eNOS. Taken together, these results identify Gab1 as a critical upstream signaling component in VEGF-induced eNOS activation and tube formation, which is dependent on PKA. Of note, this pathway is conserved in primary human ECs for VEGF-induced eNOS activation and tube formation, suggesting considerable potential in treatment of human ischemic diseases.
Footnotes
- 2To whom correspondence should be addressed. E-mail: jincailuo{at}pku.edu.cn.
Author contributions: J. Luo designed research; Y. Lu, Y.X., Y. Huo, R.Z., X.Z., X.H., and B.S. performed research; J.H., X.Y., D.-S.Z., S.K.-H., J. Li, Y. Li, M.S., and G.-S.F. contributed new reagents/analytic tools; Y. Lu, Y.X., R.Z., B.S., Y. He, and J. Luo analyzed data; and J. Luo wrote the paper.
The authors declare no conflict of interest.
↵*This Direct Submission article had a prearranged editor.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1009395108/-/DCSupplemental.